Yoo JS - Search Results

1

FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.

Kim CH, Yoo JS, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. Kim CH, et al. Among authors: yoo cg, yoo js. Int J Cancer. 2006 Apr 1;118(7):1692-8. doi: 10.1002/ijc.21573. Int J Cancer. 2006. PMID: 16231322

2

Combination of ACY-241 and JQ1 Synergistically Suppresses Metastasis of HNSCC via Regulation of MMP-2 and MMP-9.

Cho HY, Lee SW, Jeon YH, Lee DH, Kim GW, Yoo J, Kim SY, Kwon SH. Cho HY, et al. Int J Mol Sci. 2020 Sep 19;21(18):6873. doi: 10.3390/ijms21186873. Int J Mol Sci. 2020. PMID: 32961679 Free PMC article.

3

Glutamine Synthetase as a Therapeutic Target for Cancer Treatment.

Kim GW, Lee DH, Jeon YH, Yoo J, Kim SY, Lee SW, Cho HY, Kwon SH. Kim GW, et al. Int J Mol Sci. 2021 Feb 8;22(4):1701. doi: 10.3390/ijms22041701. Int J Mol Sci. 2021. PMID: 33567690 Free PMC article. Review.

4

HDAC6-selective inhibitors enhance anticancer effects of paclitaxel in ovarian cancer cells.

Yoo J, Jeon YH, Lee DH, Kim GW, Lee SW, Kim SY, Park J, Kwon SH. Yoo J, et al. Oncol Lett. 2021 Mar;21(3):201. doi: 10.3892/ol.2021.12462. Epub 2021 Jan 12. Oncol Lett. 2021. PMID: 33574940 Free PMC article.

5

HDAC8-Selective Inhibition by PCI-34051 Enhances the Anticancer Effects of ACY-241 in Ovarian Cancer Cells.

Kim JY, Han SY, Yoo J, Kim GW, Jeon YH, Lee SW, Park J, Kwon SH. Kim JY, et al. Int J Mol Sci. 2022 Aug 3;23(15):8645. doi: 10.3390/ijms23158645. Int J Mol Sci. 2022. PMID: 35955780 Free PMC article.

6

HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3.

Yi SA, Kim GW, Yoo J, Han JW, Kwon SH. Yi SA, et al. Int J Mol Sci. 2020 Aug 19;21(17):5976. doi: 10.3390/ijms21175976. Int J Mol Sci. 2020. PMID: 32825184 Free PMC article.

7

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.

Lee DH, Kim GW, Yoo J, Lee SW, Jeon YH, Kim SY, Kang HG, Kim DH, Chun KH, Choi J, Kwon SH. Lee DH, et al. Cell Death Dis. 2021 Jan 18;12(1):89. doi: 10.1038/s41419-020-03380-2. Cell Death Dis. 2021. PMID: 33462212 Free PMC article.

8

HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma.

Lee SW, Yeon SK, Kim GW, Lee DH, Jeon YH, Yoo J, Kim SY, Kwon SH. Lee SW, et al. Int J Mol Sci. 2021 Jan 29;22(3):1341. doi: 10.3390/ijms22031341. Int J Mol Sci. 2021. PMID: 33572814 Free PMC article.

9

A452, HDAC6-selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in IMiDs-resistant multiple myeloma.

Kim GW, Yoo J, Won HR, Yeon SK, Lee SW, Lee DH, Jeon YH, Kwon SH. Kim GW, et al. Leuk Res. 2020 Aug;95:106398. doi: 10.1016/j.leukres.2020.106398. Epub 2020 Jun 2. Leuk Res. 2020. PMID: 32512378

10

Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair.

Kim GW, Lee DH, Yeon SK, Jeon YH, Yoo J, Lee SW, Kwon SH. Kim GW, et al. Anticancer Res. 2019 Dec;39(12):6731-6741. doi: 10.21873/anticanres.13888. Anticancer Res. 2019. PMID: 31810938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

785 results

Search Page

Filters